We are live on
!
Find out more
DA
DSC Advisors Portfolio holdings
AUM
$11M
1-Year Est. Return
5.88%
This Fund
S&P 500
This Quarter
Est. Return
+19.14%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$91.2M
AUM Growth
-$11.2M
(-11%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-28.87%
Top 10 Holdings %
Top 10 Hldgs %
83.1%
Holding
38
New
7
Increased
17
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VYNE Therapeutics
VYNE
|
+$4.29M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$591K |
| 3 |
ServiceNow
NOW
|
+$255K |
| 4 |
UnitedHealth
UNH
|
+$199K |
| 5 |
Autodesk
ADSK
|
+$171K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$7.74M |
| 2 |
Morgan Stanley
MS
|
+$1.05M |
| 3 |
Zevra Therapeutics
ZVRA
|
+$922K |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$265K |
| 5 |
Accel Entertainment
ACEL
|
+$258K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.05% |
| 2 | Financials | 25.1% |
| 3 | Communication Services | 18.31% |
| 4 | Technology | 5.89% |
| 5 | Consumer Discretionary | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.22T
| $14.6M | 15.96% |
206,000
| – | – |
|
|
2
Morgan Stanley
MS
$339B
| $10.5M | 11.51% |
217,310
-25,027
| -10% | -$1.05M |
|
|
ATH
3
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $10.4M | 11.39% |
333,000
| – | – |
|
4
CVS Health
CVS
$137B
| $8.58M | 9.4% |
132,017
-1
| -0% | -$63 |
|
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $7.71M | 8.45% |
25,000
-75,000
| -75% | -$22M |
|
|
6
VYNE Therapeutics
VYNE
$25.4M
| $7.54M | 8.27% |
60,542
+31,712
| +110% | +$4.29M |
|
|
7
Accel Entertainment
ACEL
$989M
| $4.91M | 5.38% |
510,000
-28,200
| -5% | -$258K |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.77M | 5.23% |
42,500
-2,500
| -6% | -$265K |
|
|
9
Bristol-Myers Squibb
BMY
$124B
| $3.54M | 3.88% |
60,207
+9,887
| +20% | +$591K |
|
|
10
CALL
CVS Health
CVS
$137B
| $3.31M | 3.63% |
51,000
+40,000
| +364% | +$2.52M |
|
|
11
PUT
Morgan Stanley
MS
$339B
| $2.42M | 2.65% |
+50,000
| New | +$2.1M |
|
12
PUT
DaVita
DVA
$15.2B
| $1.98M | 2.17% |
+25,000
| New | +$1.95M |
|
13
PUT
Stryker
SYK
$123B
| $955K | 1.05% |
+5,300
| New | +$978K |
|
14
Microsoft
MSFT
$2.93T
| $831K | 0.91% |
4,085
+56
| +1% | +$10.2K |
|
|
15
Alphabet (Google) Class A
GOOGL
$4.23T
| $740K | 0.81% |
10,440
+720
| +7% | +$48.5K |
|
16
Adobe
ADBE
$94.3B
| $716K | 0.79% |
1,645
+168
| +11% | +$62.2K |
|
17
Meta Platforms (Facebook)
META
$1.64T
| $714K | 0.78% |
3,143
+99
| +3% | +$20.7K |
|
18
PayPal
PYPL
$49.9B
| $714K | 0.78% |
4,096
-89
| -2% | -$12.3K |
|
19
Netflix
NFLX
$290B
| $687K | 0.75% |
15,100
+1,370
| +10% | +$58.3K |
|
20
Visa
V
$682B
| $657K | 0.72% |
3,403
+405
| +14% | +$74K |
|
21
Salesforce
CRM
$140B
| $646K | 0.71% |
3,448
+487
| +16% | +$82.1K |
|
22
Mastercard
MA
$480B
| $643K | 0.7% |
2,174
+330
| +18% | +$93K |
|
23
Accenture
ACN
$87.9B
| $630K | 0.69% |
2,935
+365
| +14% | +$69K |
|
24
Oracle
ORCL
$364B
| $515K | 0.56% |
9,317
+1,157
| +14% | +$61.3K |
|
25
Apple
AAPL
$4.9T
| $483K | 0.53% |
5,292
-264
| -5% | -$20.5K |
|
Similar funds
RJTCONH
HSC
BGC
ACM
AG
RVM
JDR
KM
DSC Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, DSC Advisors held 38 positions worth $91.2M, down 11% from $102M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
DSC Advisors withdrew a net $26.3M in Q2 2020, closing 4 positions and reducing 7 holdings. Its most notable exit was HCA Healthcare, an estimated $7.74M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Financials and Communication Services.
Against the trend, DSC Advisors opened a new position in ServiceNow worth $292K.
- DSC Advisors's largest Q2 2020 buy was ServiceNow: 3,605 shares worth $292K.
- DSC Advisors added most to VYNE Therapeutics in Q2 2020, an estimated $4.29M increase.
- DSC Advisors's biggest Q2 2020 reduction was Morgan Stanley, cutting an estimated $1.05M.
- DSC Advisors fully exited HCA Healthcare in Q2 2020, selling an estimated $7.74M.
- DSC Advisors's ten largest holdings make up 83% of its $91.2M portfolio in Q2 2020.
- DSC Advisors opened 7 new positions and closed 4 in Q2 2020.
- DSC Advisors's portfolio value fell 11% quarter-over-quarter to $91.2M.
Based on DSC Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.